{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:46:37Z","timestamp":1786992397914,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","award":["AHZ 2015-7993"],"award-info":[{"award-number":["AHZ 2015-7993"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatriconcology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jgo.2023.101606","type":"journal-article","created":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T06:26:15Z","timestamp":1692426375000},"page":"101606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Medication optimization in older adults with advanced cancer and a limited life expectancy: A prospective observational study"],"prefix":"10.1016","volume":"14","author":[{"given":"Edwin J.","family":"Brokaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loes E.","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederiek","family":"van den Bos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanneke E.A.","family":"Portielje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jgo.2023.101606_bb0005","first-page":"7","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"10.1016\/j.jgo.2023.101606_bb0010","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/cncr.28509","article-title":"Annual report to the nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer","volume":"120","author":"Edwards","year":"2014","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.jgo.2023.101606_bb0015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jgo.2020.06.013","article-title":"Identifying potentially inappropriate medication (PIM) use in geriatric oncology","volume":"12","author":"Miller","year":"2021","journal-title":"J Geriatr Oncol"},{"issue":"4","key":"10.1016\/j.jgo.2023.101606_bb0020","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s11606-019-04837-7","article-title":"Associations between polypharmacy, symptom burden, and quality of life in patients with advanced, life-limiting illness","volume":"34","author":"Schenker","year":"2019","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1016\/j.jgo.2023.101606_bb0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00228-016-2136-8","article-title":"Adverse drug events in patients with advanced chronic conditions who have a prognosis of limited life expectancy at hospital admission","volume":"73","author":"Sevilla-Sanchez","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.jgo.2023.101606_bb0030","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1016\/S1470-2045(15)00080-7","article-title":"Polypharmacy in patients with advanced cancer and the role of medication discontinuation","volume":"16","author":"LeBlanc","year":"2015","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2023.101606_bb0035","first-page":"229","article-title":"Severe drug interactions and potentially inappropriate medication usage in elderly cancer patients","volume":"25","author":"Alkan","year":"2017","journal-title":"Support Care Cancer"},{"issue":"6","key":"10.1016\/j.jgo.2023.101606_bb0040","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jgo.2016.05.001","article-title":"Drugs prescribed for patients hospitalized in a geriatric oncology unit: potentially inappropriate medications and impact of a clinical pharmacist","volume":"7","author":"Deliens","year":"2016","journal-title":"J geriatr Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2023.101606_bb0045","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1158\/1055-9965.EPI-17-0523","article-title":"Potential medication-related problems in older breast, colon, and lung cancer patients in the United States","volume":"27","author":"Lund","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1016\/j.jgo.2023.101606_bb0050","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1177\/1078155218788698","article-title":"Evaluation of potentially inappropriate medication utilization in elderly patients with cancer at outpatient oncology unit","volume":"25","author":"Paksoy","year":"2019","journal-title":"J Oncol Pharm Pract"},{"issue":"1","key":"10.1016\/j.jgo.2023.101606_bb0055","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/10499091211003078","article-title":"Deprescribing in older adults with cancer and limited life expectancy: an integrative review","volume":"39","author":"Brokaar","year":"2022","journal-title":"Am J Hosp Palliat Care"},{"issue":"18","key":"10.1016\/j.jgo.2023.101606_bb0060","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1001\/archinternmed.2010.355","article-title":"Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy","volume":"170","author":"Garfinkel","year":"2010","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.jgo.2023.101606_bb0065","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/imj.12906","article-title":"A medication review and deprescribing method for hospitalised older patients receiving multiple medications","volume":"46","author":"McKean","year":"2016","journal-title":"Intern Med J"},{"issue":"3","key":"10.1016\/j.jgo.2023.101606_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149984","article-title":"Deprescribing in frail older people: a randomised controlled trial","volume":"11","author":"Potter","year":"2016","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.jgo.2023.101606_bb0075","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 updated AGS beers criteria(R) for potentially inappropriate medication use in older adults","volume":"67","author":"By the American Geriatrics Society Beers Criteria Update Expert, P","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.jgo.2023.101606_bb0080","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ageing\/afu145","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2","volume":"44","author":"O\u2019Mahony","year":"2015","journal-title":"Age Ageing"},{"issue":"1","key":"10.1016\/j.jgo.2023.101606_bb0085","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jgo.2020.06.014","article-title":"Prevalence and follow-up of potentially inappropriate medication and potentially omitted medication in older patients with cancer - the PIM POM study","volume":"12","author":"van Loveren","year":"2021","journal-title":"J Geriatr Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2023.101606_bb0090","article-title":"Optimising pharmacotherapy in older cancer patients with polypharmacy","volume":"29","author":"Vrijkorte","year":"2020","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.jgo.2023.101606_bb0095","series-title":"Pharmaceutical Care Practice","author":"Cipolle","year":"1998"},{"issue":"8","key":"10.1016\/j.jgo.2023.101606_bb0100","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1093\/annonc\/mdr587","article-title":"Screening older cancer patients: first evaluation of the G-8 geriatric screening tool","volume":"23","author":"Bellera","year":"2012","journal-title":"Ann Oncol"},{"issue":"20","key":"10.1016\/j.jgo.2023.101606_bb0105","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1001\/jama.291.20.2441","article-title":"Prognostic importance of comorbidity in a hospital-based cancer registry","volume":"291","author":"Piccirillo","year":"2004","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jgo.2023.101606_bb0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jgo.2020.07.010","article-title":"Impact of a pharmacist and geriatrician medication review on drug-related problems in older outpatients with cancer","volume":"12","author":"Choukroun","year":"2021","journal-title":"J Geriatr Oncol"},{"issue":"4","key":"10.1016\/j.jgo.2023.101606_bb0115","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jgo.2017.04.005","article-title":"Implementing a pharmacist-led, individualized medication assessment and planning (iMAP) intervention to reduce medication related problems among older adults with cancer","volume":"8","author":"Nightingale","year":"2017","journal-title":"J Geriatr Oncol"},{"issue":"12","key":"10.1016\/j.jgo.2023.101606_bb0120","first-page":"4105","article-title":"Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study","volume":"26","author":"Whitman","year":"2018","journal-title":"Support Care Cancer"},{"issue":"8","key":"10.1016\/j.jgo.2023.101606_bb0125","doi-asserted-by":"crossref","first-page":"468","DOI":"10.4140\/TCP.n.2017.468","article-title":"The DE-PHARM project: a pharmacist-driven Deprescribing initiative in a nursing facility","volume":"32","author":"Pruskowski","year":"2017","journal-title":"Consult Pharm"},{"issue":"4","key":"10.1016\/j.jgo.2023.101606_bb0130","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/jgs.16278","article-title":"Deprescribing in older people approaching end of life: a randomized controlled trial using STOPPFrail criteria","volume":"68","author":"Curtin","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jgo.2023.101606_bb0135","author":"IKNL"},{"issue":"1","key":"10.1016\/j.jgo.2023.101606_bb0140","first-page":"71","article-title":"The development and evaluation of an oncological palliative care deprescribing guideline: the \u2018OncPal deprescribing guideline\u2019","volume":"23","author":"Lindsay","year":"2015","journal-title":"Support Care Cancer"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406823002035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406823002035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:00:06Z","timestamp":1761818406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406823002035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S1879406823002035"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2023.101606","relation":{},"ISSN":["1879-4068"],"issn-type":[{"value":"1879-4068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication optimization in older adults with advanced cancer and a limited life expectancy: A prospective observational study","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2023.101606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101606"}}